CI
Clal Insurance’s Novo Nordisk NVO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $897K | Hold |
13,000
| – | – | 0.01% | 98 |
|
2025
Q1 | $918K | Buy |
13,000
+3,000
| +30% | +$212K | 0.01% | 92 |
|
2024
Q4 | $860K | Buy |
10,000
+4,000
| +67% | +$344K | 0.01% | 89 |
|
2024
Q3 | $714K | Buy |
+6,000
| New | +$714K | 0.01% | 102 |
|
2023
Q1 | – | Sell |
-7,000
| Closed | -$947K | – | 144 |
|
2022
Q4 | $947K | Buy |
7,000
+1,000
| +17% | +$135K | 0.01% | 126 |
|
2022
Q3 | $598K | Hold |
6,000
| – | – | 0.01% | 133 |
|
2022
Q2 | $669K | Sell |
6,000
-6,000
| -50% | -$669K | 0.01% | 138 |
|
2022
Q1 | $1.33M | Buy |
+12,000
| New | +$1.33M | 0.01% | 132 |
|
2021
Q3 | – | Sell |
-7,500
| Closed | -$628K | – | 219 |
|
2021
Q2 | $628K | Sell |
7,500
-3,500
| -32% | -$293K | 0.01% | 162 |
|
2021
Q1 | $752K | Hold |
11,000
| – | – | 0.01% | 150 |
|
2020
Q4 | $718K | Buy |
11,000
+3,000
| +38% | +$196K | 0.01% | 114 |
|
2020
Q3 | $555K | Hold |
8,000
| – | – | 0.01% | 113 |
|
2020
Q2 | $524K | Sell |
8,000
-2,000
| -20% | -$131K | 0.01% | 114 |
|
2020
Q1 | $610K | Buy |
+10,000
| New | +$610K | 0.02% | 99 |
|